Titan International Inc. (NYSE:TWI) shares fell -9.35% in last trading session and ended the day at $2.91. TWI Gross Margin is 9.70% and its has a return on assets of -9.70%. Titan International Inc. (NYSE:TWI) quarterly performance is -62.21%.
Titan International Inc. (NYSE:TWI) announced it has filed petitions for relief from imports of off-the-road tires that are imported to the U.S.
Amicus Therapeutics, Inc. (NASDAQ:FOLD) ended the last trading day at $7.31. Company weekly volatility is calculated as 8.84% and price to cash ratio as 3.86. Amicus Therapeutics, Inc. (NASDAQ:FOLD) showed a weekly performance of -19.05%.
Amicus Therapeutics, Inc. (NASDAQ:FOLD) provided its full-year 2016 strategic outlook and financial guidance. Migalastat is an oral personalized medicine intended to treat Fabry disease in patients who have amenable genetic mutations. Amicus has built a commercial organization in the EU that is prepared to launch migalastat upon approval.
On 11 January, DSP Group Inc. (NASDAQ:DSPG) shares advanced 1.83% and was closed at $8.90. DSPG EPS growth in last 5 year was 19.60%. DSP Group Inc. (NASDAQ:DSPG) year to date (YTD) performance is -5.72%.
DSP Group Inc. (NASDAQ:DSPG) announced the launch of SparkPA – a revolutionary RF Power Amplifier (PA) for the high performance and technically challenging 802.11ac Access Point market, using a standard CMOS Process from TSMC (TWSE: 2330, NYSE: TSM).
Exxon Mobil Corporation (NYSE:XOM) shares fell -1.34% in last trading session and ended the day at $73.69. XOM Gross Margin is 27.00% and its has a return on assets of 5.80%. Exxon Mobil Corporation (NYSE:XOM) quarterly performance is -6.22%.
Exxon Mobil Corporation (NYSE:XOM) said that, it subsidiary, Esso Exploration & Production Nigeria Limited (EEPNL), in production sharing contract with the Nigerian National Petroleum Corporation (NNPC) and its co-venturer on the OML 133, Shell Nigeria Exploration and Production Company (SNEPCO), has built and equipped Geoscience workrooms for 24 universities in Nigeria at a total cost of over N7 billion under its University Assistance Programme (UAP).
PTC Therapeutics, Inc. (NASDAQ:PTCT) caters to the Healthcare space. Its weekly performance is -24.89%. On the last day of trading company shares ended up at $23.18. PTC Therapeutics, Inc. (NASDAQ:PTCT) distance from 50-day simple moving average (SMA50) is -21.56%.
PTC Therapeutics, Inc. (NASDAQ:PTCT) provided a corporate update, which will be detailed at the company’s presentation at the 34th Annual J.P. Morgan Healthcare Conference. Stuart W. Peltz, Ph.D., Chief Executive Officer will present the company’s corporate strategy and anticipated 2016 milestones at 9:30 a.m. PST on Wednesday, Jan. 13, 2016.
Leave a Reply